Enteral Feeding Formulas Market Size & Growth Report by 2028

report image

Enteral Feeding Formulas Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Standard Formulas, Peptide Formulas, Specialized Formulas, and Others), Application (Respiratory Disorders, Cancer, Gastroenterology Disorders, Diabetes, Liver/Kidney Disease, Neurology, Post COVID-19, and Others), Form (Powder, Liquid, and Semi-Solid), Age Group [(Children (Till 18 Years) and Adult (18+ Years)], Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Geography

Report Code: TIPRE00003840 | No. of Pages: No. of Pages150 | Category: Pharmaceuticals | Status: Prebook

The enteral feeding formulas market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028 at a CAGR of 6.0% between 2022 and 2028.

Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal diseases. According to the article in Heathline, in 2021, around 40% of people across the world were affected by functional gastrointestinal disorder. According to Medscape, in developed countries, the most common cause of small-bowel obstruction (SBO) is intra-abdominal adhesions, accounting for ~65 to 75% of cases, followed by hernias. In contrast, in developing countries, SBO is primarily caused by hernias (30–40%), adhesions (about 30%), and tuberculosis (about 10%). According to the article published by World Journal of Emergency Surgery, bowel obstruction is an important cause of morbidity and mortality accounting for nearly 30,000 deaths and more than US$3 billion per year in direct medical costs. Bowel obstruction is responsible for ~15% of hospital admissions for acute abdominal pain in the US, and ~ 20% of cases need acute surgical care.

Crohn’s disease is a complex, long-lasting (chronic) disorder that primarily affects the digestive system. It is most common disease in North America and Western Europe and has a prevalence of 100 to 300 per 100,000 in these regions. According to Medline Plus, more than half a million in North American and Western European people are currently suffering from Crohn’s disease. Patients suffering from gastrointestinal disease are at an increased risk of nutritional deterioration due to fasting for the diagnostic tests, therapeutic dietary restriction, and appetite loss due to anorexia or altered nutritional requirement. Gastrointestinal disease patients cannot consume food orally. Therefore, enteral route is preferred to provide the required nutrients. A few brands that caters to gastroenterology disorders are Ensure, Ensure HN, Ensure Powder, Isocal, Lonalac Powder, Meritene, Meritene Powder, Osmolite, Osmolite HN, Portagen Powder, Sustacal, Sustagen Powder, and Travasorb.  Therefore, the growing prevalence of gastrointestinal diseases drives the growth of the enteral feeding formulas market

MARKET DYNAMICS


The growth of the enteral feeding formulas market is majorly attributed to the rising prevalence of gastrointestinal disorders and the increasing prevalence of cachexia. However, mechanical or enteral tube-related problems hamper the growth of the market. The usage of next-generation technology for proper enteral nutrition feeding is projected to offer lucrative opportunities for the growth of the enteral feeding formulas market during the forecast period.

Strategic Insights

Report Coverage - Enteral Feeding Formulas Market
Report CoverageDetails
Market Size Value inUS$ 7,803.45 Million in 2021
Market Size Value byUS$ 11,726.37 Million by 2028
Growth rateCAGR of 6.0% from 2022 to 2028
Forecast Period2022-2028
Base Year2021
No. of Pages150
Historical data availableYes
Segments coveredType, Application, Form, Age Group, Distribution Channel, and Geography
Regional scopeNorth America; Europe; Asia Pacific; Latin America; MEA
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available

MARKET SCOPE


The "Global Enteral Feeding Formulas Market Analysis to 2028"  report aims to provide an overview of enteral feeding formulas market with detailed market segmentation based on type, application, form, age group, and distribution channel. The report provides key statistics based on the financial performances of the leading enteral feeding formulas market players. It also offers key trends and opportunities in the market.

MARKET SEGMENTATION


The global enteral feeding formulas market is segmented on the basis of type, application, form, age group, and distribution channel. Based on type, the market is segmented into standard formulas, peptide formulas, specialized formulas, and others. By application, the market is segmented into respiratory disorders, cancer, gastroenterology disorders, diabetes, liver/kidney disease, neurology, post COVID-19, and others. Based on form, the enteral feeding formulas market is segmented into powder, liquid, and semi-solid. Based on age group, the market is bifurcated into adult (18+ years) and children (till 18 years). In terms of distribution channel, the market is segmented into hospital pharmacies, retail stores, and others.

REGIONAL FRAMEWORK


The global enteral feeding formulas market is segmented into five major regions—North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries globally along with trends and opportunities prevailing in the regions.

North America dominated the enteral feeding formulas market capturing more than 41% market share in 2021. The market growth in North America is driven by the growing prevalence of gastroenterology disorders in the US.  According to Centers for Disease Control and prevention, the number of adults with diagnosed ulcers in the United States was 14.8 million in 2020. The number of visits to emergency departments with diseases of the digestive system as the primary diagnosis was 7.9 million in 2020 in the United States. As a result, the enteral feeding formulas acts as a medium to overcome or prevent such illnesses owing to the source of nutrients (protein, carbohydrates, etc.) received from the enteral feeding formula products.

 The below figure shows the revenue growth trend in the enteral feeding formulas market:

Enteral Feeding Formulas Market

Get more information on this report :

Source: The Insight Partners Analysis

The report analyzes factors, such as drivers, restraints, opportunities, and future trends, which impact the growth of the enteral feeding formulas market. It also provides exhaustive Porter's five forces analysis of the factors influencing the market.

IMPACT OF COVID-19 PANDEMIC

According to a research article published in Critical Care, 2020, the novel coronavirus may invade the gastrointestinal tract, neurological systems, and kidneys, which may adversely affect the nutrition delivery among COVID-19 patients. As per the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, gastric/renal enteral formulas are recommended for severe COVID-19 patients admitted in the intensive care units (ICUs). Hence, the demand for enteral feeding formulas increased globally due to the rising number of COVID-19 patients, especially in ICUs.

MARKET PLAYERS


The report covers key developments in the enteral feeding formulas market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, and patents and events. In addition, acquisitions, and partnership & collaborations are among the inorganic growth strategies witnessed in the market. These activities have paved way for the expansion of business and customer base of market players. The players operating in the enteral feeding formulas market are anticipated to experience lucrative growth opportunities in the future owing to the rising demand for enteral feeding formulas.

The report also includes the profiles of key enteral feeding formulas market companies along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players with information, such as company profiles, components and services offered, financial information of last 3 years, and key development in past five years.

Below mentioned is the list of a few companies engaged in the enteral feeding formulas market.

  • Abbott
  • Nestle Health Science
  • Magnacal Renal
  • UNILEVER
  • Danone
  • Kate Farms
  • Nutricia
  • Smartfish AS
  • Fresenius Kabi AG
  • Hormel Foods Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Market Research

Get more information on this report :

The List of Companies

1. Abbott
2. B. Braun Melsungen AG
3. Danone
4. Fresenius Kabi India Pvt. Ltd
5. Global Health Products, Inc.
6. Mead Johnson and Company, LLC
7. Meiji Holdings Co., Ltd.
8. Nestlé
9. Hormel Foods Corporation
10. Victus, Inc

TIPRE00003840
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




tip-analyst

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount